WaferGen Signs Exclusive Distribution Agreements for SmartSlide Micro-Incubation System
News Jul 29, 2008
WaferGen signs exclusive SmartSlide distribution agreement in Switzerland, Taiwan and the Nordic Region.
WaferGen Biosystems, Inc. announced the signing of exclusive distribution agreements for the company's SmartSlide™ Micro-Incubation System with Bucher Biotec AG in Switzerland, Unimed Healthcare Inc. in Taiwan and AH diagnostics AS in the Nordic region (Denmark, Sweden, Norway and Finland).
The distributor agreements cover WaferGen's entire family of SmartSlide Micro-Incubation System products. Bucher Biotec, Unimed Healthcare and AH diagnostics are each distributors of products and services to cell biologists and stem cell researchers in the life science markets within their geographic areas of focus.
WaferGen's SmartSlide Micro-Incubation System is a first-of-its-kind family of integrated fluidics exchange micro-incubation products that work seamlessly with inverted microscopes. This technology is enabling cell biology and stem cell researchers to conduct complex time lapse imaging studies to characterize, differentiate and proliferate cells, as well as grow stem, primary and other difficult to cultivate cells in consistently optimal physiological conditions.
"These key distributor agreements represent yet another important milestone in our strategic efforts to expand the reach of our SmartSlide Micro-Incubation System into new key foreign markets," stated Alnoor Shivji, WaferGen's chairman and chief executive officer.
"This innovative platform is already providing critical performance advantages to researchers in several valuable international markets through our existing distributor agreements in Germany, France, the United Kingdom, Australia, Singapore and the Benelux. In keeping with this strategy, we expect to continue to build our SmartSlide Micro-Incubation System customer base with additional international distributor agreements this year."
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018